Financials
- Market Capitalization 11.75 B
- Employee 925
- Founded 2012
- CEO Herriot Tabuteau
- Website www.axsome.com
- Headquarter Delaware, United States
- FIGI BBG00B6G7GL7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 809 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 531.00 USD | -1.06% | -0.74% | +10.63% | +25.35% | 12.24 B USD | ||
| 823 | SMMT Summit Therapeutics Inc. - Common Stock | 15.30 USD | +0.33% | -4.20% | +5.96% | -22.96% | 11.88 B USD | ||
| 843 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 59.20 USD | +0.14% | -0.74% | +5.56% | +1.02% | 11.44 B USD | ||
| 858 | TECH Bio-Techne Corp - Common Stock | 71.36 USD | +0.08% | +0.62% | +29.02% | +34.67% | 11.17 B USD |
Frequently asked questions about Axsome Therapeutics, Inc. - Common Stock
What is the Axsome Therapeutics, Inc. - Common Stock stock price today?
The current price of Axsome Therapeutics, Inc. - Common Stock (AXSM) is 228.28. Over the past 24 hours, the stock has changed by -2.36%. Follow the AXSM chart for real-time price dynamics.
What is the stock ticker of Axsome Therapeutics, Inc. - Common Stock?
Axsome Therapeutics, Inc. - Common Stock trades under the ticker AXSM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Axsome Therapeutics, Inc. - Common Stock stock going up?
AXSM has changed by -5.79% over the last week, -10.25% over the last month, and +75.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Axsome Therapeutics, Inc. - Common Stock net income for the last quarter?
Axsome Therapeutics, Inc. - Common Stock reported net income of -64.54 M for the last quarter. The previous quarter showed -28.56 M, which means net income changed by -126.00%.
How many employees does Axsome Therapeutics, Inc. - Common Stock have?
As of the latest available data, Axsome Therapeutics, Inc. - Common Stock has 925 employees. Workforce size can provide additional context about the company's scale and operations.
What is Axsome Therapeutics, Inc. - Common Stock EBITDA?
Axsome Therapeutics, Inc. - Common Stock EBITDA is -60.83 M, and its EBITDA margin is -31.81%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Axsome Therapeutics, Inc. - Common Stock stock?
You can buy Axsome Therapeutics, Inc. - Common Stock (AXSM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Axsome Therapeutics, Inc. - Common Stock stock?
Investing in Axsome Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AXSM chart and related analysis on metatrader.com as part of your research.